VRTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Vertex Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 546.12 USD -2.12% Market Closed

Market Cap: $138.6B

	Vertex Pharmaceuticals Inc NASDAQ:VRTX	US
G	Grupo Ecoener SA MAD:ENER	ES
D	DoorDash Inc NASDAQ:DASH	US
D	DTE Energy Co F:DGY	US
S	S Hotels and Resorts PCL SET:SHR	TH
A	Able Global Bhd KLSE:ABLEGLOB	MY
	Asia Cement Co Ltd KRX:183190	KR
	Compass Pathways PLC NASDAQ:CMPS	UK
O	Onion Global Ltd OTC:OGBLY	CN
V	Vodafone Group PLC F:VODI	UK
B	BMEX Gold Inc OTC:MRIRF	CA
	HSC Technology Group Ltd ASX:HSC	AU

Profitability Summary

Vertex Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

86%

Declining Gross Margin

88% > 86%

Exceptional Operating Margin

39%

Strong 3Y Average Operating Margin

41%

Declining Operating Margin

47% > 39%

Exceptional Net Margin

35%

Sustainable 3Y Average Net Margin

21%

Declining Net Margin

35% > 35%

Exceptional Free Cash Flow Margin

30%

Strong 3Y Average Free Cash Flow Margin

18%

Declining Free Cash Flow Margin

41% > 30%

Positive ROE

24%

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.